ZonMw
Reducing Drug Harm – Pre-applications Phase 1 (NWA)
Phase 1 pre-proposal deadline; assessment of foreign organisations by 23 June 2026. Phase 2 full application deadline: 30 March 2027.
Last verified:
The ZonMw Reducing Drug Harm (NWA) call funds research on the mechanisms of drug-related harm and effective societal interventions in the Netherlands, with Phase 1 pre-proposals receiving up to €1,067,737.75 and a single joint consortium advancing to Phase 2 for up to €4,270,951 over five years. A mandatory consortium, comprising a main applicant, co-applicant, and cooperation partner, must include Dutch knowledge institutions, societal organisations, and citizen involvement. This one-off call takes a two-stage approach: only four Phase 1 pre-proposals will advance to mandatory synergy workshops, where selected teams will merge into a single joint application.
Details
| Funder | ZonMw |
| Budget | Up to €1,067,737.75 per pre-proposal (Phase 1); €4,270,951 total for Phase 2 joint application |
| Deadline | 7 July 2026 |
| Duration | Up to 5 years |
| Consortium | Required — minimum: main applicant, co-applicant, and cooperation partner; Dutch knowledge institutions, societal organisations, and citizens eligible |
| Application | 2-stage: Phase 1 pre-proposal (deadline 7 July 2026) → Phase 2 full application via synergy workshops (Nov 2026–Feb 2027), full proposal deadline 30 March 2027 |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Funds research on mechanisms of drug(-related) harm and effective societal interventions in the Netherlands. Consortium required (main applicant + co-applicant + cooperation partner); researchers, knowledge institutions, and societal organisations may apply. Max 4 pre-proposals selected in Phase 1; a single joint consortium is formed in Phase 2 via mandatory NWO-facilitated synergy workshops. Submitted via Mijn ZonMw.
Who Should Apply
- •Researchers and knowledge institutions based in the Netherlands
- •Multidisciplinary teams combining academic expertise with societal-organisation partners and citizen representatives
- •Applicants able to commit to mandatory synergy workshops (November 2026, February 2027) if selected in Phase 1
- •Consortia with a clear main applicant, named co-applicant, and cooperation partner ready to form a joint entity in Phase 2
Key Dates
- •Phase 1 pre-proposal deadline: 7 July 2026 (19 days away); foreign-organisation assessment deadline 23 June 2026
- •Phase 1 to Phase 2 transition: Mandatory synergy workshops November 2026, February 2027; single joint consortium formed
- •Phase 2 full application deadline: 30 March 2027; project duration up to five years
Tips for Applicants
- ✓Only four Phase 1 pre-proposals advance to Phase 2; your pre-proposal must articulate a clear evidence gap in drug-harm reduction and name a feasible, differentiated intervention pathway to compete.
- ✓Ensure your synergy-workshop commitment is explicit in Phase 1, this is mandatory if you advance, and absence of confirmed participant availability will disqualify you in Phase 2 consensus-building.
- ✓Citizen and societal-organisation co-applicants must be named and active in Phase 1; they are not add-ons. ZonMw expects lived experience or practitioner expertise to shape the research design, not just the dissemination plan.
Frequently Asked Questions
How much funding does the Reducing Drug Harm NWA Phase 1 offer?
Phase 1 pre-proposals receive up to €1,067,737.75 each; four selected teams advance to Phase 2, where a single joint consortium applies for up to €4,270,951 over five years.
Who must be in a Reducing Drug Harm NWA consortium?
A consortium requires a main applicant, a co-applicant, and a cooperation partner, with all members being Dutch knowledge institutions, societal organisations, or citizen representatives.
What happens between Phase 1 and Phase 2 in the Reducing Drug Harm NWA?
Four Phase 1 pre-proposals are selected; their teams participate in mandatory synergy workshops (November 2026, February 2027) to merge into a single joint consortium before submitting the Phase 2 full application.
Is the Reducing Drug Harm NWA a recurring call?
No, this is a one-off call with a single funding cycle.
What is the project duration for the Reducing Drug Harm NWA?
Projects funded in Phase 2 may run for up to five years.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from ZonMw
Strengthening Organization of Healthcare on the ABCSSS Islands
Deadline: 7 Jul 2026Up to €60,000 per project (total call budget €360,000)Reducing Drug Harm – Pre-proposals Phase 1 (NWA)
Deadline: 7 Jul 2026Up to €1,067,737.75 per pre-proposal (Phase 1); €4,270,951 total for Phase 2 joint applicationStrengthening Organization of Healthcare System – ABCSSS Islands
Deadline: 7 Jul 2026Up to €60,000 per project (total call budget €360,000)Rubicon 2026-2
Deadline: 1 Sept 2026€3,145,000 (total round budget)Promising Medicines for ME/CFS — Call Drug Repurposing
Deadline: 8 Sept 2026€600k–€1M per project (total pool €3.5M)
Browse Related
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free